Modelling Mitchell-Riley Syndrome in vitro using iPS cells derived from RFX6 mutant patient
The forkhead transcription factor Regulatory Factor X, 6 (RFX6) is essential for the development of the mammalian pancreas. In humans, RFX6 mutations are responsible for Mitchell-Riley Syndrome (MRS), which is characterized by neonatal diabetes with pancreatic hypoplasia. Similarly, Rfx6 mutant mice...
Main Author: | Alpagu, Yunus |
---|---|
Other Authors: | Ray Dunn |
Format: | Thesis |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/75844 |
Similar Items
-
Human iPS-derived pre-epicardial cells direct cardiomyocyte aggregation expansion and organization in vitro
by: Tan, Jun Jie, et al.
Published: (2021) -
Transgene Excision Has No Impact on In Vivo Integration of Human iPS Derived Neural Precursors
by: Major, Tamara, et al.
Published: (2012) -
Identification of small molecules for human hepatocyte expansion and iPS differentiation
by: Shan, Jing, et al.
Published: (2014) -
Immortalized striatal precursor neurons from Huntington’s disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics
by: Akimov, Sergey S, et al.
Published: (2021) -
Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
by: Mungenast, Alison, et al.
Published: (2017)